Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Ono Pharmaceutical had annual revenue of 515.79B JPY with 5.94% growth. Ono Pharmaceutical had revenue of 118.75B in the quarter ending March 31, 2026, with 5.73% growth.

• Revenue: 515.79B
• Revenue Growth: +5.94%
• P/S Ratio: 2.05
• Revenue / Employee: 120.31M
• Employees: 4,287
• Market Cap: 1.06T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	515.79B	28.91B	5.94%
Mar 31, 2025	486.87B	-15.80B	-3.14%
Mar 31, 2024	502.67B	55.49B	12.41%
Mar 31, 2023	447.19B	85.83B	23.75%
Mar 31, 2022	361.36B	52.08B	16.84%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error